Teradyne shows leadership character in two of the hottest themes, semiconductor testing and robotics: it has posted back-to-back strong earnings and every dip to its 50-day moving average gets bought. It also leads industrial automation through Universal Robots and MiR, helping factories automate repetitive, high-precision, labor-heavy tasks. x.com 

Teradyne is a high-quality AI infrastructure name with significant long-term upside, as a surge in free cash flow has left it debt-free and tracking toward about $600 million a year. The price target remains $435 by mid-2027. The latest earnings were not flawless: limited visibility and potential lumpiness in the second half of 2026 create substantial uncertainty that will overhang the stock. x.com 

Teradyne's Q2 outlook coming in below its Q1 results is concerning when demand should be sky-high, and if later quarters look the same, its P/E would be too high to justify buying. x.com 

Teradyne is a multiyear compounder as both the cobot layer of factory automation and the test layer for AI chips. Its Universal Robots unit makes collaborative robots that let factories retrofit a line in a weekend instead of a year, and it is the spine of half the factory floors automating in 2026. Its semiconductor test gear is what every AI chip passes through, its own or Advantest's. Forward EPS of $9.51 at 35x anchors fair value at $333, near the current $337.88; the 320s would be a buy. … Show more

Teradyne supplies the testing behind the AI revolution, with fundamentals accelerating and technicals confirming. x.com 

Teradyne looks less dominant in CPO testing than expected after it acknowledged Advantest's capabilities on its earnings call. Per GF Securities, low TSMC SoIC yields have led the industry to cut 2026 CPO shipment forecasts, and Teradyne enters a 2H26 transition: Q2 guidance implies a 6% sequential drop, 55-60% of 2026 revenue falls in the first half, and it trades at 47x 2026 earnings. GF still sees long-term CPO upside, with 2027 CPO revenue possibly $800M. x.com  x.com 

Teradyne's test business is surging because rising AI chip complexity multiplies testing demand. Q2 revenue was a record $1.329 billion, up about 104% and above consensus, and Semiconductor Test revenue rose 128% to $1.122 billion. Management said AI is now its primary growth engine, contributing about $1.2 billion of Q2 revenue across compute, HBM and networking. More sophisticated GPUs, ASICs and HBM need far more testing, making its high-end ATE mission-critical. x.com 

Advantest beat because it simply grew at its own historical upcycle pace, which Wall Street underestimated. Revenue came in at ¥367B versus ¥336B consensus and a ¥360B forecast; analysts modeled just 2.3% sequential growth, while Advantest's median in an upcycle is closer to 10%. Earlier reports from Teradyne, TSMC and Disco had already signaled HBM4 pulling tester demand forward; Teradyne memory-test revenue below $170M or an AI mix under 65% would have broken that chain. x.com 

Aehr Test Systems may be the best of breed in chip equipment, with the strongest year-over-year EPS growth in the space as a maker of chip test equipment. It is no longer the momentum play it was, but today's push off its short-term low on massive volume looks like the real deal. x.com 

Semiconductors look to be topping and should resolve lower into September, as the market prices in slowing capex in 2027. Strong earnings beats look in the rearview mirror; if Q2 was near peak, big beats are expected, and record backlogs are typical at peak demand and can be cut fast once spending slows. The semiconductor ETF has completed its upside correction and is losing steam, with new lows likely by September, which would weigh on a Nasdaq expected to slip toward its 200-day average. x.com  … Show more